Send Inquiry

Request To Call Back

60 Mg Daclatasvir Tablet

Get a Price/Quote

MOQ : 10 Boxes

60 Mg Daclatasvir Tablet Specification

Packaging Type
Blister Pack / Box

Origin of Medicine
India

Life Span
24 months from date of manufacture

Salt Composition
Daclatasvir Dihydrochloride

Pacakaging (Quantity Per Box)
28 Tablets per box

Dosage Form
Oral Tablet

Indication
For the treatment of chronic hepatitis C genotype 1 and 3 infections

Brand Name
Daclahep / Natdac / Dacihep (depending on manufacturer)

Drug Type
Allopathic, Allopathic

Ingredients
Daclatasvir Dihydrochloride

Physical Form
Tablet, Tablet

Function
Antiviral medication for HCV, Antiviral - Hepatitis C treatment

Recommended For
Adults with chronic Hepatitis C virus infection

Dosage
60 mg once daily or as directed by physician

Dosage Guidelines
As prescribed by healthcare professional

Suitable For
Adults, Adults only

Quantity
28 Tablets

Storage Instructions
Store below 30C, away from moisture and direct sunlight

Patient Information Leaflet
Included in the box

Regulatory Approval
WHO-GMP Certified

Language on Packaging
English

Minimum Order Quantity
1 Box

Usage
For use as part of combination antiviral treatment in Hepatitis C

Box Dimensions
Approx. 13.5 5 2.5 cm (L W H)

Side Effects
Headache, fatigue, nausea, diarrhea, insomnia

Route of Administration
Oral

Therapeutic Class
Antiviral agents

Contraindications
Not recommended for patients with known hypersensitivity to Daclatasvir or any component of the tablet

Marketed By
Aprazer Healthcare Pvt. Ltd.

Drug Interactions
Consult physician; may interact with other antiviral medications or CYP3A inhibitors/inducers

Prescription Required
Yes

60 Mg Daclatasvir Tablet Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Day

Delivery Time
5-7 Days

Main Domestic Market
All India

About 60 Mg Daclatasvir Tablet

Experience the extraordinary power of 60 Mg Daclatasvir Tablet-a new release in the renowned antiviral segment and a best-seller, now available with a remarkable price cut! Expertly formulated by Aprazer Healthcare Pvt. Ltd. in WHO-GMP certified facilities, this opulent antiviral agent targets chronic Hepatitis C in adults when prescribed as part of a combination treatment. With its grandiose efficacy against Hepatitis C genotype 1 and 3 infections, each box contains 28 tablets, meticulously packed and accompanied by a patient information leaflet. Suitable for adults only, prescription required.

Advanced Antiviral for Hepatitis C Treatment

The 60 Mg Daclatasvir Tablet is engineered for oral administration as a potent component in the management of chronic Hepatitis C virus infection. Its primary area of application is in adult patients with genotype 1 or 3 hepatitis C, who are undergoing combination antiviral therapy. Featuring convenient once-daily dosing, the blister-packed tablets are sized perfectly for secure and hygienic storage. Usage is strictly guided by prescription, ensuring customized care at clinical and home settings alike.

Quality Assurance & Domestic Market Engagement

Our 60 Mg Daclatasvir Tablet is dispatched with meticulous packaging, preserving product integrity during transit. Marketed extensively across India, this grandiose antiviral meets proposal amounts for wholesale and minimum order quantities of one box. Certified with WHO-GMP, the medicine is a testament to regulated quality. Sample policy details and certifications are available upon request, ensuring partners receive confidence and clarity in every shipment for domestic markets.

FAQ's of 60 Mg Daclatasvir Tablet:

Q: How should the 60 Mg Daclatasvir Tablet be taken for optimal results?

A: The tablet is administered orally, usually once daily, as part of a combination antiviral treatment for chronic Hepatitis C. Dosage and duration should follow your healthcare provider's prescription.

Q: What are the major benefits of using Daclatasvir for Hepatitis C?

A: Daclatasvir is renowned for its extraordinary efficacy in reducing the viral load of Hepatitis C, particularly genotypes 1 and 3, when used in combination therapy. This can lead to improved liver health and prevent disease progression.

Q: When is Daclatasvir not recommended for use?

A: This medication should not be used in patients with known hypersensitivity to Daclatasvir or any components of the tablet. Always inform your physician about all allergies and medications before starting treatment.

Q: Where can Daclatasvir Tablets be applied or accessed?

A: These tablets are mainly provided to adults diagnosed with chronic Hepatitis C, typically distributed through pharmacies and healthcare providers upon prescription. They are suitable for use at home under medical supervision.

Q: What regulatory approvals and certifications does this product hold?

A: The 60 Mg Daclatasvir Tablet is manufactured in a WHO-GMP certified facility, ensuring compliance with international medicinal standards and quality control protocols.